198 related articles for article (PubMed ID: 33860868)
1. Epigallocatechin-3-gallate inhibits the growth of three-dimensional in vitro models of neuroblastoma cell SH-SY5Y.
Wan X; Wang W; Liang Z
Mol Cell Biochem; 2021 Aug; 476(8):3141-3148. PubMed ID: 33860868
[TBL] [Abstract][Full Text] [Related]
2. Survivin knockdown increased anti-cancer effects of (-)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells.
Hossain MM; Banik NL; Ray SK
Exp Cell Res; 2012 Aug; 318(13):1597-610. PubMed ID: 22507272
[TBL] [Abstract][Full Text] [Related]
3. SU5416 and EGCG work synergistically and inhibit angiogenic and survival factors and induce cell cycle arrest to promote apoptosis in human malignant neuroblastoma SH-SY5Y and SK-N-BE2 cells.
Mohan N; Karmakar S; Banik NL; Ray SK
Neurochem Res; 2011 Aug; 36(8):1383-96. PubMed ID: 21472456
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin gallate (EGCG) potentiates the cytotoxicity of rotenone in neuroblastoma SH-SY5Y cells.
Chung WG; Miranda CL; Maier CS
Brain Res; 2007 Oct; 1176():133-42. PubMed ID: 17900545
[TBL] [Abstract][Full Text] [Related]
5. (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.
Zhu BH; Chen HY; Zhan WH; Wang CY; Cai SR; Wang Z; Zhang CH; He YL
World J Gastroenterol; 2011 May; 17(18):2315-25. PubMed ID: 21633597
[TBL] [Abstract][Full Text] [Related]
6. Exposure of the SH-SY5Y Human Neuroblastoma Cells to 50-Hz Magnetic Field: Comparison Between Two-Dimensional (2D) and Three-Dimensional (3D) In Vitro Cultures.
Consales C; Butera A; Merla C; Pasquali E; Lopresto V; Pinto R; Pierdomenico M; Mancuso M; Marino C; Benassi B
Mol Neurobiol; 2021 Apr; 58(4):1634-1649. PubMed ID: 33230715
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin gallate inhibits sphere formation of neuroblastoma BE(2)-C cells.
Nishimura N; Hartomo TB; Pham TV; Lee MJ; Yamamoto T; Morikawa S; Hasegawa D; Takeda H; Kawasaki K; Kosaka Y; Yamamoto N; Kubokawa I; Mori T; Yanai T; Hayakawa A; Takeshima Y; Iijima K; Matsuo M; Nishio H
Environ Health Prev Med; 2012 May; 17(3):246-51. PubMed ID: 21909813
[TBL] [Abstract][Full Text] [Related]
8. (-)-Epigallocatechin-3-Gallate protects SH-SY5Y cells against 6-OHDA-induced cell death through STAT3 activation.
Wang L; Xu S; Xu X; Chan P
J Alzheimers Dis; 2009; 17(2):295-304. PubMed ID: 19221405
[TBL] [Abstract][Full Text] [Related]
9. Real Time Monitoring of Inhibition of Adipogenesis and Angiogenesis by (-)-Epigallocatechin-3-Gallate in 3T3-L1 Adipocytes and Human Umbilical Vein Endothelial Cells.
Tang W; Song H; Cai W; Shen X
Nutrients; 2015 Oct; 7(10):8871-86. PubMed ID: 26516907
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin 3-gallate attenuates neuronal damage induced by 3-hydroxykynurenine.
Jeong JH; Kim HJ; Lee TJ; Kim MK; Park ES; Choi BS
Toxicology; 2004 Jan; 195(1):53-60. PubMed ID: 14698567
[TBL] [Abstract][Full Text] [Related]
11. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.
Zhu BH; Zhan WH; Li ZR; Wang Z; He YL; Peng JS; Cai SR; Ma JP; Zhang CH
World J Gastroenterol; 2007 Feb; 13(8):1162-9. PubMed ID: 17451194
[TBL] [Abstract][Full Text] [Related]
12. Blood brain barrier permeability of (-)-epigallocatechin gallate, its proliferation-enhancing activity of human neuroblastoma SH-SY5Y cells, and its preventive effect on age-related cognitive dysfunction in mice.
Pervin M; Unno K; Nakagawa A; Takahashi Y; Iguchi K; Yamamoto H; Hoshino M; Hara A; Takagaki A; Nanjo F; Minami A; Imai S; Nakamura Y
Biochem Biophys Rep; 2017 Mar; 9():180-186. PubMed ID: 28956003
[TBL] [Abstract][Full Text] [Related]
13. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex.
Lim YC; Cha YY
J Surg Oncol; 2011 Dec; 104(7):776-80. PubMed ID: 21725973
[TBL] [Abstract][Full Text] [Related]
15. The epigallocatechin gallate derivative Y
Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of apoptosis with the involvement of calpain and caspase cascades in human malignant neuroblastoma SH-SY5Y cells exposed to flavonoids.
Das A; Banik NL; Ray SK
Int J Cancer; 2006 Dec; 119(11):2575-85. PubMed ID: 16988947
[TBL] [Abstract][Full Text] [Related]
17. Expression of lncRNA CCAT2 in children with neuroblastoma and its effect on cancer cell growth.
Chen M; Zhao M; Hou Y; Zhu B
Mol Cell Biochem; 2021 Apr; 476(4):1871-1879. PubMed ID: 33475889
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells.
Zhang D; Al-Hendy M; Richard-Davis G; Montgomery-Rice V; Rajaratnam V; Al-Hendy A
Fertil Steril; 2010 Oct; 94(5):1887-93. PubMed ID: 19819432
[TBL] [Abstract][Full Text] [Related]
19. The application of proteomics for studying the neurorescue activity of the polyphenol (-)-epigallocatechin-3-gallate.
Weinreb O; Amit T; Youdim MB
Arch Biochem Biophys; 2008 Aug; 476(2):152-60. PubMed ID: 18211800
[TBL] [Abstract][Full Text] [Related]
20. [Effects of miR-144 on proliferation, apoptosis and cisplatin resistance by targeting MYCN in pediatric neuroblastoma].
Liu HJ; Li GL; Lei PC
Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):516-521. PubMed ID: 31357838
[No Abstract] [Full Text] [Related]
[Next] [New Search]
